NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma

Although being the first-line treatment of advanced hepatocellular carcinoma (HCC), sorafenib (SOR) outcome is limited due to drug resistance and low tumor accumulation. Herein, with MnO(2) as photothermal agent and chlorine6 (Ce6) as photosensitizer, a tumor-targeting and NIR-triggered multifunctio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chonggao, Cheng, Xiaolan, Peng, Hao, Zhang, Yewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489827/
https://www.ncbi.nlm.nih.gov/pubmed/36125619
http://dx.doi.org/10.1186/s11671-022-03729-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489827/
https://www.ncbi.nlm.nih.gov/pubmed/36125619
http://dx.doi.org/10.1186/s11671-022-03729-w

Ejemplares similares